World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
62
Citations
11662
World Ranking
8975
National Ranking
2543

John W. Babich publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where John W. Babich sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 283 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

John W. Babich D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where John W. Babich sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 62 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

John W. Babich is affiliated with Cornell University in the United States. Their research primarily spans the field of Medicine, with a focus on subfields including Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Materials Chemistry, and Surgery.

The scientist's work covers several main topics, such as Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Medical Imaging Techniques and Applications, Peptidase Inhibition and Analysis, Cardiac Structural Anomalies and Repair, Lanthanide and Transition Metal Complexes, and Cerebrospinal fluid and hydrocephalus.

Frequently publishing venues for John W. Babich include:

  • Journal of Clinical Oncology
  • Research Square (Research Square)
  • Cancer Research
  • Fluids and Barriers of the CNS
  • Translational Oncology

Recent papers authored or coauthored by John W. Babich include:

  • Decreased CSF clearance and increased brain amyloid in Alzheimer's disease, 2022, Fluids and Barriers of the CNS
  • Advances in PSMA theranostics, 2022, Translational Oncology
  • Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer, 2020, Molecular Pharmaceutics
  • Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates, 2020, Human Gene Therapy
  • Phase I study of 225Ac-J591 for men with metastatic castration-resistant prostate cancer (mCRPC), 2021, Journal of Clinical Oncology

Among frequent coauthors collaborating with John W. Babich are:

  • James M. Kelly
  • Anastasia Nikolopoulou
  • Thomas M. Jeitner
  • Joseph R. Osborne
  • Alejandro Amor-Coarasa

Best Publications

  • A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.

    K. P. Maresca;S. M. Hillier;F. J. Femia;D. Keith

  • Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

    Shawn M. Hillier;Kevin P. Maresca;Frank J. Femia;John C. Marquis

  • 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

    Shawn M. Hillier;Kevin P. Maresca;Genliang Lu;Ross D. Merkin

  • A ticket to ride : peptide radiopharmaceuticals

    A J Fischman;J W Babich;H W Strauss

  • Metabolic Imaging With β-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia

    Vasken Dilsizian;Timothy M. Bateman;Steven R. Bergmann;Roger Des Prez

  • Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer

    Ying Chen;Catherine A. Foss;Youngjoo Byun;Sridhar Nimmagadda

  • An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy

    Nikki A. Thiele;Victoria Brown;James M. Kelly;Alejandro Amor-Coarasa

  • Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.

    Mark Bartholomä;John Valliant;Kevin P. Maresca;John Babich

  • Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules

    Paolo A. Netti;Leena M. Hamberg;John W. Babich;Diane Kierstead

  • Bridging the gap between in vitro and in vivo imaging: isostructural Re and 99mTc complexes for correlating fluorescence and radioimaging studies.

    Karin A. Stephenson;Sangeeta Ray Banerjee;Travis Besanger;Oyebola O. Sogbein

  • Bifunctional single amino acid chelates for labeling of biomolecules with the {Tc(CO)3}+ and {Re(CO)3}+ cores. Crystal and molecular structures of [ReBr(CO)3(H2NCH2 C5H4N)], [Re(CO)3{(C5H4 NCH2)2NH}]Br,

    Sangeeta Ray Banerjee;Murali K. Levadala;Neva Lazarova;Lihui Wei

  • New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.

    Sangeeta Ray Banerjee;Kevin P. Maresca;Lynn Francesconi;John Valliant

  • A convenient synthesis, chemical characterization and reactivity of [Re(CO)3(H2O)3]Br: the crystal and molecular structure of [Re(CO)3(CH3CN)2Br]

    Neva Lazarova;Shelly James;John Babich;Jon Zubieta

  • PSMA as a target for radiolabelled small molecules

    Matthias Eder;Michael Eisenhut;John Babich;Uwe Haberkorn

  • Glu-Ureido-Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers.

    Klaus Kopka;Martina Benešová;Cyril Bařinka;Uwe Haberkorn

  • A new strategy for the preparation of peptide-targeted radiopharmaceuticals based on an fmoc-lysine-derived single amino acid chelate (SAAC). automated solid-phase synthesis, NMR characterization, and in vitro screening of fMLF(SAAC)G and fMLF[(SAAC-Re(CO)3)+]G.

    Karin A Stephenson;Jon Zubieta;Sangeeta Ray Banerjee;Murali K Levadala

  • Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma.

    R. J. Ott;M. Brada;M. A. Flower;J. W. Babich

  • Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection.

    John W. Babich;Howard Solomon;Marilyn C. Pike;Daniel Kroon

  • Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters

    Alan J. Fischman;Ali A. Bonab;John W. Babich;E. Prather Palmer

  • Effect of “co-ligand” on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides

    J.W. Babich;A.J. Fischman

  • Synthesis and Characterization of Organohydrazino Complexes of Technetium, Rhenium, and Molybdenum with the {M(η1-HxNNR)(η2-HyNNR)} Core and Their Relationship to Radiolabeled Organohydrazine-Derivatized Chemotactic Peptides with Diagnostic Applications

    David J. Rose;Kevin P. Maresca;Terrence Nicholson;Alan Davison

Frequent Co-Authors

Jon Zubieta
Jon Zubieta Syracuse University
Alan J. Fischman
Alan J. Fischman Harvard University
Robert H. Rubin
Robert H. Rubin Brigham and Women's Hospital
Nathaniel M. Alpert
Nathaniel M. Alpert Harvard University
Uwe Haberkorn
Uwe Haberkorn Heidelberg University
Stanley J. Goldsmith
Stanley J. Goldsmith Cornell University
Neil H. Bander
Neil H. Bander Cornell University
Ronald G. Tompkins
Ronald G. Tompkins Harvard University
David M. Nanus
David M. Nanus Cornell University
Walter Mier
Walter Mier University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Chemistry degree in the USA opens doors to diverse career opportunities, particularly in the pharmaceutical and forensic science fields. Many students consider transitioning to roles such as pharmaceutical sales representatives, where understanding chemistry enhances product knowledge and client trust. Curious about compensation? Discover how much do pharmaceutical sales reps make to better evaluate this path.

Alternatively, if you are interested in healthcare, becoming a pharmacist is a rewarding option. The journey requires commitment and education; learn more about how long does it take to become a pharmacist before making this decision.

For those fascinated by forensic investigations, becoming an autopsy technician is a critical role that combines scientific knowledge and meticulous attention to detail. Check out the earning potential by exploring how much do autopsy techs make. Moreover, if affordability is a concern, you can consider enrolling in the cheapest online forensic science degree programs available, which provide flexible and cost-effective education options.

Exploring these related online degrees and career pathways can help Chemistry students align their passion with practical career goals while making informed decisions about education and job prospects.

Best Scientists Citing John W. Babich

Trending Scientists

Recently Published Articles